For over two decades, Americans have watched from afar as countries like Japan, Australia, and those in the EU enjoyed access to advanced sunscreen ingredients that offered better protection, easier application, and less greasy formulas. That long wait is nearly over.
This week, the FDA announced it is moving forward with approval for bemotrizinol — a powerful, broad-spectrum UV filter that has been a gold standard in sunscreens abroad since the early 2000s. The ingredient, also known as Tinosorb S, blocks both UVA and UVB rays more effectively than many existing options and remains stable in sunlight without breaking down quickly.
The delay has been a source of frustration for dermatologists and consumer advocates, who have long called for the FDA to catch up with global regulators. Sunscreen is a critical tool in preventing skin cancer, the most common cancer in the United States, and experts argue that outdated regulatory hurdles have kept better formulations out of reach.
Bemotrizinol is expected to appear in a new generation of sunscreens that feel lighter, go on clearer, and provide more reliable protection. Manufacturers are already preparing to launch products containing the ingredient once final approval is granted.
"This is a game-changer for American consumers," said Dr. Rachel Martin, a dermatologist at Northwestern Medicine. "We finally have access to ingredients that have been proven safe and effective for years elsewhere."
The approval process still requires a final signature, but the FDA's announcement signals that change is imminent. For those who have been importing sunscreens from overseas or sticking with subpar options, the end of the sunscreen nightmare is finally in sight.